Stock listing

NASDAQ:LUMO Lumos Pharma Inc Stock

Follow Lumos Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:LUMO

$4.34 USD

Close on Dec 11, 2024 · No longer trades

Mar 19, 2020 to last close -50.5% · weekly closes, Mar 19, 2020 – Dec 11, 2024
Lowest – highest close
$1.45 – $35.91 USDSince Mar 19, 2020 · lowest Jul 18, 2024 · highest Dec 30, 2020

Delisted NASDAQ:LUMO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LUMO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Lumos Pharma Inc on 6ix

Calls
16 calls with a replay · 16 with a transcript · latest Aug 1, 2024
Decks
42 decks · latest Aug 1, 2024

Events

CallWhenStatus
Lumos Pharma (LUMO) Q2 2024 Earnings CallThu, Aug 01, 2024 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q1 2024 Earnings CallWed, May 15, 2024 · 8:30 AM ETReplay
Lumos Pharma (LUMO) Q4 2023 Earnings CallThu, Mar 07, 2024 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q3 2023 Earnings CallWed, Nov 08, 2023 · 8:30 AM ETReplay
Lumos Pharma (LUMO) Q2 2023 Earnings CallWed, Aug 09, 2023 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q1 2023 Earnings CallWed, May 03, 2023 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q4 2022 Earnings CallWed, Mar 01, 2023 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q3 2022 Earnings CallMon, Nov 14, 2022 · 8:30 AM ETReplay
Lumos Pharma (LUMO) Q2 2022 Earnings CallTue, Aug 09, 2022 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q1 2022 Earnings CallTue, May 10, 2022 · 4:30 PM ETReplay
All 16 calls
CallWhenStatus
Lumos Pharma (LUMO) Q4 2021 Earnings CallThu, Mar 10, 2022 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q3 2021 Earnings CallWed, Nov 03, 2021 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q2 2021 Earnings CallThu, Aug 05, 2021 · 11:00 AM ETReplay
Lumos Pharma (LUMO) Q1 2021 Earnings CallWed, May 05, 2021 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q4 2020 Earnings CallTue, Mar 09, 2021 · 4:30 PM ETReplay
Lumos Pharma (LUMO) Q3 2020 Earnings CallTue, Nov 10, 2020 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Q2 2024 Earnings PresentationEarnings8 slidesAug 1, 2024
Investor Presentation (June 2024)Investor deck44 slidesJun 5, 2024
Q1 2024 Earnings PresentationEarnings14 slidesMay 15, 2024
FY2023 Earnings PresentationEarnings10 slidesMar 7, 2024
Investor Presentation (November 2023)Investor deck57 slidesNov 15, 2023
Technical Presentation (November 2023)Technical37 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings10 slidesAug 9, 2023
Technical Presentation (June 2023)Technical42 slidesJun 21, 2023
Q1 2023 Earnings PresentationEarnings8 slidesMay 3, 2023
FY2022 Earnings PresentationEarnings8 slidesMar 1, 2023
All 42 decks
DeckKindSlidesDate
Technical Presentation (December 2022)Technical42 slidesDec 12, 2022
Technical Presentation (November 2022)Technical55 slidesNov 14, 2022
Q2 2022 Earnings PresentationEarnings11 slidesAug 10, 2022
Q1 2022 Earnings PresentationEarnings11 slidesMay 10, 2022
FY2021 Earnings PresentationEarnings10 slidesMar 10, 2022
Q3 2021 Earnings PresentationEarnings9 slidesNov 3, 2021
Q2 2021 Earnings PresentationEarnings9 slidesAug 5, 2021
Q1 2021 Earnings PresentationEarnings11 slidesMay 5, 2021
Technical Presentation (April 2021)Technical55 slidesApr 29, 2021
FY2020 Earnings PresentationEarnings16 slidesMar 9, 2021
Q3 2020 Earnings PresentationEarnings14 slidesNov 10, 2020
Q2 2020 Earnings PresentationEarnings14 slidesAug 13, 2020
Q1 2020 Earnings PresentationEarnings12 slidesMay 28, 2020
NewLink Genetics — Merger or Acquisition (September 2019)Merger or acquisition22 slidesSep 30, 2019
NewLink Genetics — Q1 2019 Earnings PresentationEarnings9 slidesMay 8, 2019
NewLink Genetics — FY2018 Earnings PresentationEarnings10 slidesFeb 27, 2019
NewLink Genetics — Q3 2018 Earnings PresentationEarnings10 slidesNov 1, 2018
NewLink Genetics — Q2 2018 Earnings PresentationEarnings10 slidesJul 31, 2018
NewLink Genetics — Q1 2018 Earnings PresentationEarnings11 slidesMay 3, 2018
NewLink Genetics — American Association of Cancer Research (AACR) Annual Meeting 2018Conference26 slidesApr 16, 2018
NewLink Genetics — FY2017 Earnings PresentationEarnings9 slidesMar 1, 2018
NewLink Genetics — 36th Annual J.P. Morgan Healthcare Conference (January 2018)Conference25 slidesJan 8, 2018
NewLink Genetics — Q3 2017 Earnings PresentationEarnings10 slidesNov 2, 2017
NewLink Genetics — Q2 2017 Earnings PresentationEarnings10 slidesJul 28, 2017
NewLink Genetics — Corporate Update (June 2017)Corporate update6 slidesJun 8, 2017
NewLink Genetics — Q1 2017 Earnings PresentationEarnings9 slidesMay 4, 2017
NewLink Genetics — FY2016 Earnings PresentationEarnings7 slidesFeb 28, 2017
NewLink Genetics — Q3 2016 Earnings PresentationEarnings6 slidesNov 1, 2016
NewLink Genetics — Q2 2016 Earnings PresentationEarnings10 slidesJul 29, 2016
NewLink Genetics — Q1 2016 Earnings PresentationEarnings10 slidesApr 29, 2016
NewLink Genetics — FY2015 Earnings PresentationEarnings10 slidesFeb 29, 2016
NewLink Genetics — BioCentury NewsMakers in the Biotech Industry 2013Conference38 slidesSep 26, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lota S Zoth
Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past)
Director · Nov 2, 2012 – Dec 12, 2024 · Past
Paolo Pucci
Other companies: Replimune Group, Inc. (Director · Since at least Apr 1, 2020); West Pharmaceutical Services, Inc. (Director · Since at least Sep 12, 2016); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Dyax Corp (Director · Nov 1, 2011 – Jan 13, 2016 · Past); ArQule Inc (Chief Executive Officer, Director · Jun 9, 2008 – Jan 16, 2020 · Past)
Director · Nov 12, 2015 – May 23, 2018 · Past
Richard J. Hawkins
Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); SciClone Pharmaceuticals Inc (Director · Oct 13, 2017 – Oct 13, 2017 · Past)
Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past
Joseph Saluri
Other companies: Cibus, Inc. (General Counsel, EVP-Corp Dev · Jul 20, 2017 – Jul 20, 2017 · Past); Zevra Therapeutics, Inc. (Director · Apr 15, 2015 – Apr 25, 2023 · Past)
Director · Nov 10, 2011 – May 12, 2017 · Past
Aaron Schuchart
Other companies: Spyre Therapeutics, Inc. (Chief Business Officer · May 22, 2017 – Feb 28, 2019 · Past)
Chief Business Officer · May 19, 2021 – Dec 12, 2024 · Past
Eugene P Kennedy
Other companies: Galera Therapeutics, Inc. (Chief Medical Officer · Sep 1, 2022 – Feb 25, 2023 · Past)
Chief Medical Officer · Nov 13, 2017 – Feb 1, 2021 · Past
Kevin M Lalande
Other companies: Molecular Templates Inc (Director · Jun 3, 2022 – Sep 27, 2024 · Past)
Director · May 5, 2022 – Dec 12, 2024 · Past
Bradley J PowersGeneral Counsel · Aug 3, 2019 – Dec 12, 2024 · Past
Brian WileyChief Commercial Officer · Jan 2, 2013 – Mar 9, 2018 · Past
Carl W LangrenChief Financial Officer · Nov 7, 2013 – Apr 1, 2021 · Past
All 16 people
PersonSeat
David J LundquistDirector · Nov 10, 2011 – Mar 5, 2012 · Past
John C McKewChief Scientific Officer · Mar 18, 2020 – Dec 12, 2024 · Past
Lori D LawleyChief Financial Officer · Aug 1, 2018 – Dec 12, 2024 · Past
Pisit Duke PitukcheewanontChief Medical Officer · Jan 4, 2024 – Dec 12, 2024 · Past
Sarah AlexanderDirector · Nov 10, 2011 – Nov 16, 2011 · Past
William J RamseyQuality Assurance Officer · Nov 10, 2011 – Jun 1, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Lumos Pharma Inc.